The food-tech company reported in a press release that the successful pilot is the first of three milestones towards commercial production and launch of ProteVin, planned in 2022. The two additional milestones:
- Generating initial demand from the market and engagement with a first customer by the end of 2021
- Entering into a production agreement with a subcontractor.
- Meeting the parameters determined that define the product. In tests performed by an independent lab, ProteVin met all parameters defined, including concentration of the protein, composition of amino acids, digestibility, light color, a product free of contaminants and allergens, and its compliance with food regulations and other quality parameters.
- Compliance with taste, flavor and odor requirements. The company says ProteVin achieved neutral taste, flavor and odor requirements, without typical aftertaste and odor of various types of plant-based proteins.
- Ability to supply samples for customers' approval: NextFerm said it produced a quantity of the protein sufficient to supply samples in the amount required for approval by potential customers, and added that customer testing includes integrating the protein in product prototypes.
“We have recently begun sending commercial samples of ProteVi™ to potential customers worldwide," Noy said. "On the production side, we are in discussions with several potential subcontractors, in order to launch the product in 2022, as planned, and look forward to update our investors on our progress.” The product can be marketed in the U.S., Europe and other countries.